Neoadjuvant therapies can improve tolerability, reduce tumor volume to facilitate surgery,
and assess subsequent treatment response. Therefore, there is much enthusiasm for …

Prostate cancer is a major cause of death in males. Cyproterone acetate (CPA), the steroidal
anti-androgen for part of androgen deprivation therapy, may block the androgen-receptor …

Background A predictive model for biochemical recurrence (BCR) of prostate cancer (PCa)
after neoadjuvant androgen deprivation therapy (nADT) has not been established. This …

Over the past decade or so with the treatment of high risk and oligometastatic disease has
undergone a paradigm shift. Improvements in surgical techniques especially the robot …

Background Prostate cancer holds a substantial presence in the global cancer landscape,
and a considerable proportion of diagnoses occur at late stages, particularly in India …

Objectives: To evaluate the clinical efficacy of neoadjuvant chemohormonal therapy (NCHT)
combined with laparoscopic radical prostatectomy in high-risk prostate cancer (PCa) …

Simple Summary Prostate cancer is the second leading cause of cancer deaths in men.
Attempts to improve patient outcomes include trials of neoadjuvant androgen deprivation …

The incidence rate of prostate cancer is showing an upward trend year by year, gradually
becoming an important disease affecting the health of middle-aged and elderly men. The …

Рак предстательной железы (РПЖ) является одной из наиболее важных, социально
значимых медицинских проблем, так как данная опухоль лидирует в структуре …

Neurogenic bladder patients require lifelong care, but timely identification and intervention
can help to prevent renal deterioration and provide excellent outcomes. Among neonates …